My watch list  

Meglumine antimoniate

Meglumine antimoniate
Systematic (IUPAC) name
CAS number 133-51-7
ATC code P01CB01
PubChem 64953
Chemical data
Formula Variable
Mol. mass Variable
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes  ?

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Meglumine_antimoniate". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE